COR
Cencora, Inc.
NYSE · Healthcare · Medical - Distribution · US
$350.00
+2.79%Next report
Analyst consensus
- Next report date
- Nov 4, 2026
- EPS estimate
- $4.58
- Revenue estimate
- $88.0B
Latest reported
- Last report date
- Nov 4, 2026
- EPS actual
- $4.66
- EPS estimate
- $4.58
- Revenue actual
- $88.4B
- Revenue estimate
- $88.0B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +1.0%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $376
- PT range
- $330 – $400
- Analysts
- 9
8 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 4, 2026 | $4.58 | $4.66 | Beat 1.75% | $88.4B |
| Aug 5, 2026 | $4.35 | $4.48 | Beat 2.99% | $84.8B |
| May 6, 2026 | $4.82 | $4.75 | Miss -1.45% | $78.4B |
| Feb 4, 2026 | $4.05 | $4.08 | Beat 0.74% | $85.9B |
| Nov 5, 2025 | $3.79 | $3.84 | Beat 1.32% | $83.7B |
| Aug 6, 2025 | $3.85 | $4.00 | Beat 3.90% | $80.7B |
| Feb 5, 2025 | $3.50 | $3.73 | Beat 6.57% | $81.5B |
| Jan 30, 2024 | — | $2.98 | — | $72.3B |
| Nov 2, 2023 | $2.79 | $1.72 | Miss -38.37% | $68.9B |
| Aug 2, 2023 | $2.82 | $2.92 | Beat 3.51% | $66.9B |
| May 2, 2023 | $3.30 | $3.50 | Beat 6.09% | $63.5B |
| Feb 1, 2023 | $2.65 | $2.71 | Beat 2.30% | $62.8B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 4, 2026